What is BioIntelligence Technologies?
BioIntelligence Technologies operates at the intersection of biotechnology and data analytics, providing advanced solutions for the biomanufacturing sector. Their product suite, including the BiOptic+ for real-time bioprocess variable measurement and the BioAnalyst for in-depth analysis, is designed to enhance process efficiency, reduce variability, and optimize fermentation. By offering intelligent biomanufacturing tools, the company empowers clients to improve overall performance and achieve long-term success in a competitive industry. The recent major strategic investment suggests a scaling phase for the company, aiming to expand its market reach and technological capabilities.
How much funding has BioIntelligence Technologies raised?
BioIntelligence Technologies has raised a total of $5M across 1 funding round:
Other Financing Round
$5M
Other Financing Round (2024): $5M with participation from AQC Capital, Real Ventures, Investissement Quebec, Amplify Capital, and Innospark Ventures
Key Investors in BioIntelligence Technologies
AQC Capital
AQC Capital is an investment firm focused on supporting Quebec-based startups across all industries, providing financial backing and guidance from early stages to market success with over $160 million under management.
Real Ventures
Real Ventures backs visionary founders building innovative tech companies with large-scale positive impacts, offering guidance and stage-specific support to entrepreneurs.
Investissement Quebec
Investissement Quebec is a provincial corporation dedicated to assisting in the growth of investment in Quebec, contributing to economic development and job creation through various financial solutions.
What's next for BioIntelligence Technologies?
With this latest infusion of capital, BioIntelligence Technologies is poised to accelerate its product development and market penetration. The company's focus on intelligent biomanufacturing solutions aligns with the growing demand for data-driven optimization in the life sciences and pharmaceutical industries. Future strategic initiatives will likely involve expanding their software analytics platform, enhancing real-time monitoring capabilities, and forging deeper partnerships within the biomanufacturing ecosystem. This funding will be instrumental in solidifying their position as a leader in providing actionable insights for bioprocess optimization.
See full BioIntelligence Technologies company page
